Japanese biotech firm uses roundworms in early screening for pancreatic cancer | South China Morning Post

Hirotsu Bio Science, a Japanese biotech firm, says it has developed the world’s first early screening test for pancreatic cancer using roundworms. In November 2022, it launched the “N-NOSE plus Pancreas” test, which uses the worm’s highly sensitive sense of smell. The company edits the worms’ genetic code so that th…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.